Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 May;21(5):603-10.
doi: 10.1007/s00467-006-0026-5. Epub 2006 Mar 7.

A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome

Affiliations
Review

A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome

Carlos E Araya et al. Pediatr Nephrol. 2006 May.

Abstract

Idiopathic minimal lesion nephrotic syndrome (IMLNS) was proposed to be a disorder of T-cell dysfunction by Shalhoub in 1974. The mechanisms by which T-cells increase glomerular permeability have remained elusive (and unproven). There is evidence that IMLNS may be due to a circulating factor released from activated T-cells. In recent years, efforts have been made to identify this pathogenetic cytokine as well as to understand the mechanism(s) for the increased release of this factor. This review attempts to critically analyze the available published data. Using different methodologies, investigators have focused on the production of cytokines in patients with IMLNS during relapse and remission. This has resulted in a plethora of data without definitive conclusions. The pathogenetic cytokine has not been identified, and it is questionable whether there is a Th2 dominance in IMLNS. The review of the available data illustrates the difficulties encountered when one is studying the cytokine secretory pattern in patients with IMLNS. Differences in patient population, type of cells studies, sample preservation, and methodology used to measure cytokines are some of the factors that could account for the disparity of observed results.

PubMed Disclaimer

References

    1. Kidney Int. 1991 Sep;40(3):453-60 - PubMed
    1. Kidney Int. 1994 May;45(5):1311-7 - PubMed
    1. Arch Dis Child. 1981 Jul;56(7):517-24 - PubMed
    1. Lancet. 1970 Mar 14;1(7646):542-3 - PubMed
    1. Clin Exp Immunol. 1985 Sep;61(3):601-7 - PubMed

LinkOut - more resources